Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Comorbidities & Risk Factors for Developing SLE

Thomas R. Collins  |  August 15, 2017

MADRID—Researchers have found that systemic lupus erythematosus (SLE) is independently linked with bipolar disorder and say the findings point to a need for greater awareness of psychiatric problems in patients with SLE.

In work led by investigators at Tel Aviv University in Israel and presented at the 2017 Annual European Congress on Rheumatology (EULAR), researchers analyzed data from the medical database of Clalit Health Services, which includes a chronic disease registry with continuous real-time input. The study included data for 5,018 SLE patients and 25,090 matched controls.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Investigators found a higher prevalence of bipolar disorder among SLE patients than among controls—0.62% vs. 0.26% (P<0.001). In a multivariate analysis, SLE was found to be independently associated with the disorder, with an odds ratio of 1.74 (P=o.012).

“Neuropsychiatric manifestations among lupus patients are present in virtually all lupus patients,” said Shmuel Tiosano, MD, who presented the findings and is a rheumatologist and researcher at Sheba Medical University. “We think the neuroinflammation is a key factor here.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Overlap exists among SLE patients who complain of physical difficulties and bipolar disorder patients, because they also have physical complaints and often neglect their health. In this study, research found that bipolar disorder has a link to the SLE. “Their physical complaints, we eventually found out, had been a manifestation of lupus,” he said. “That’s what’s so interesting about it.”

“Lupus patients usually have many, many physical complaints and all sorts of emotional complaints,” Dr. Tiosano said. Caregivers should try to distinguish between depressive symptoms due to their underlying illness and signs there could be a psychiatric disease at work.

Neuropsychiatric symptoms develop in 20–70% of SLE patients and half the time these symptoms develop ahead of SLE. The onset of mood symptoms can happen any time in the course of SLE and at any severity level of disease.

Nailfold Capillaroscopy
In another study, researchers in Belgium conducted the first systematic review of nailfold capillaroscopy and SLE, finding correlations they say merit further investigation.2 Nailfold changes on capillaroscopy have been seen in SLE, but no clear role has yet been established for the approach in classification or staging.

In this study, researchers did a literature review of all published studies involving patients with SLE who’d had capillaroscopy performed. They reviewed findings from 27 studies after excluding other studies based on such things as ACR criteria for SLE not being met and having fewer than five patients in a study.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:Bipolar Spectrum DisorderEULARlocationnailfold capillaroscopyruralsystemic lupus erythematosus (SLE)urban

Related Articles

    Rheumatologists Find Nailfold Capillaroscopy an Increasingly Useful Diagnostic Tool

    October 18, 2017

    Interest in viewing the nail capillaries dates to the late 17th century. Later research by Maurice Raynaud and others in the late 19th and early 20th century first established a direct link between the nailfold capillaries and certain medical conditions. Although underutilized in the past, with the advent of modern digital equipment and the validation…

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Bipolar Disorder, Nailfold Capillaroscopy Score, Urban Location Among Risk Factors for Developing Lupus

    October 17, 2017

    MADRID—Researchers have found that systemic lupus erythematosus (SLE) is independently linked with bipolar disorder and say the findings point to a need for greater awareness of psychiatric problems in patients with SLE. In work led by investigators at Tel Aviv University in Israel and presented at the 2017 Annual European Congress on Rheumatology (EULAR), researchers…

    Fibromyalgia & Bipolar Spectrum Disorder: A Shared Pathophysiology May Lead to Better Drug Targets

    March 21, 2016

    Patients suffering from fibromyalgia and those suffering from bipolar spectrum disorder experience similar symptoms. Research suggests that these diseases may share a pathophysiological process, particularly a similar impairment in the prefrontal-limbic networks of the brain. A new editorial addresses how a better understanding of the potential shared biological underpinning of these diseases could result in unique drug targets…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences